US 10619160
Compositions and methods for inhibiting expression of RRM2 genes
granted A61KA61K48/00A61P
Quick answer
US patent 10619160 (Compositions and methods for inhibiting expression of RRM2 genes) held by Arrowhead Pharmaceuticals, Inc. expires Mon Apr 09 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Arrowhead Pharmaceuticals, Inc.
- Grant date
- Tue Apr 14 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 09 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 21
- CPC classes
- A61K, A61K48/00, A61P, A61P35/00